Zobrazeno 1 - 10
of 1 631
pro vyhledávání: '"Michael Bachmann"'
Autor:
Peter Jagd Sørensen, Claes Nøhr Ladefoged, Vibeke Andrée Larsen, Flemming Littrup Andersen, Michael Bachmann Nielsen, Hans Skovgaard Poulsen, Jonathan Frederik Carlsen, Adam Espe Hansen
Publikováno v:
Tomography, Vol 10, Iss 9, Pp 1397-1410 (2024)
The Brain Tumor Segmentation (BraTS) Challenge has been a main driver of the development of deep learning (DL) algorithms and provides by far the largest publicly available expert-annotated brain tumour dataset but contains solely preoperative examin
Externí odkaz:
https://doaj.org/article/82109056b1184a5a93cf9a7cbd10d27d
Autor:
Alexander Malcolm Rykkje, Jonathan Frederik Carlsen, Vibeke Andrée Larsen, Jane Skjøth-Rasmussen, Ib Jarle Christensen, Michael Bachmann Nielsen, Hans Skovgaard Poulsen, Thomas Haargaard Urup, Adam Espe Hansen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Several prognostic factors are known to influence survival for patients treated with IDH-wildtype glioblastoma, but unknown factors may remain. We aimed to investigate the prognostic implications of early postoperative MRI findings. A total
Externí odkaz:
https://doaj.org/article/97a9dfc337114ad7912d092d25ccd4ea
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
The importance of the immune system in regulating tumor growth by inducing immune cell-mediated cytotoxicity associated with patients’ outcomes has been highlighted in the past years by an increasing life expectancy in patients with cancer on treat
Externí odkaz:
https://doaj.org/article/678ae7a2ef5e4297af8ae6150c60b7c5
Autor:
Liliana R. Loureiro, Lydia Hoffmann, Christin Neuber, Luise Rupp, Claudia Arndt, Alexandra Kegler, Manja Kubeil, Christoph E. Hagemeyer, Holger Stephan, Marc Schmitz, Anja Feldmann, Michael Bachmann
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background Chimeric antigen receptor (CAR) T-cells are a promising approach in cancer immunotherapy, particularly for treating hematologic malignancies. Yet, their effectiveness is limited when tackling solid tumors, where immune cell infilt
Externí odkaz:
https://doaj.org/article/40cdac5b7b9a489091bc53905b399ab5
Autor:
Bolette Mikela Vilmun, George Napolitano, Andreas Lauritzen, Elsebeth Lynge, Martin Lillholm, Michael Bachmann Nielsen, Ilse Vejborg
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1823 (2024)
Assessing a woman’s risk of breast cancer is important for personalized screening. Mammographic density is a strong risk factor for breast cancer, but parenchymal texture patterns offer additional information which cannot be captured by density. We
Externí odkaz:
https://doaj.org/article/1a75b660af9644f6b5f310b6a4918b3f
Autor:
Torsten Tonn, Hans Klingemann, Winfried S Wels, Jiri Eitler, Natalie Wotschel, Laurent Boissel, Michael Bachmann, Wiebke Rackwitz, Venugopal Gudipati, Nivedha Murali Shankar, Anastasia Sidorenkova, Johannes B Huppa, Paola Ortiz-Montero, Corinna Opitz, Stephan R Künzel, Susanne Michen, Achim Temme, Liliana Rodrigues Loureiro, Anja Feldmann
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background The antitumor activity of natural killer (NK) cells can be enhanced by specific targeting with therapeutic antibodies that trigger antibody-dependent cell-mediated cytotoxicity (ADCC) or by genetic engineering to express chimeric antigen r
Externí odkaz:
https://doaj.org/article/635e8a9c7ed146e6934cedabb216012a
Autor:
Dávid Szöllősi, Polett Hajdrik, Hedvig Tordai, Ildikó Horváth, Dániel S. Veres, Bernadett Gillich, Kanni Das Shailaja, László Smeller, Ralf Bergmann, Michael Bachmann, Judith Mihály, Anikó Gaál, Bálint Jezsó, Balázs Barátki, Dorottya Kövesdi, Szilvia Bősze, Ildikó Szabó, Tamás Felföldi, Erzsébet Oszwald, Parasuraman Padmanabhan, Balázs Zoltán Gulyás, Nazha Hamdani, Domokos Máthé, Zoltán Varga, Krisztián Szigeti
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract The important roles of bacterial outer membrane vesicles (OMVs) in various diseases and their emergence as a promising platform for vaccine development and targeted drug delivery necessitates the development of imaging techniques suitable fo
Externí odkaz:
https://doaj.org/article/0d18a8a1a33a427bb6f55cbff27178a3
Autor:
Karla E. G. Soto, Liliana R. Loureiro, Tabea Bartsch, Claudia Arndt, Alexandra Kegler, Nicola Mitwasi, Laura Drewitz, Lydia Hoffmann, Haidy A. Saleh, Eugenia Crespo, Maria Mehnert, Cansu Daglar, Hinrich Abken, Frank Momburg, Michael Bachmann, Anja Feldmann
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Despite the success of chimeric antigen receptor (CAR) T-cells especially for treating hematological malignancies, critical drawbacks, such as “on-target, off-tumor” toxicities, need to be addressed to improve safety in translating to clinical ap
Externí odkaz:
https://doaj.org/article/504decca751c445b97cdaa60cf18debc
Autor:
Alexandra Kegler, Laura Drewitz, Claudia Arndt, Cansu Daglar, Liliana Rodrigues Loureiro, Nicola Mitwasi, Christin Neuber, Karla Elizabeth González Soto, Tabea Bartsch, Larysa Baraban, Holger Ziehr, Markus Heine, Annabel Nieter, Andres Moreira-Soto, Arne Kühne, Jan Felix Drexler, Barbara Seliger, Markus Laube, Domokos Máthé, Bernadett Pályi, Polett Hajdrik, László Forgách, Zoltán Kis, Krisztián Szigeti, Ralf Bergmann, Anja Feldmann, Michael Bachmann
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to millions of infections and deaths worldwide. As this virus evolves rapidly, there is a high need for treatment options that
Externí odkaz:
https://doaj.org/article/6f9dbf914b914345892894df2414c939
Autor:
Jacob Johansen, Cecilie Mørck Offersen, Jonathan Frederik Carlsen, Silvia Ingala, Adam Espe Hansen, Michael Bachmann Nielsen, Sune Darkner, Akshay Pai
Publikováno v:
Diagnostics, Vol 14, Iss 1, p 69 (2023)
DWI/FLAIR mismatch assessment for ischemic stroke patients shows promising results in determining if patients are eligible for recombinant tissue-type plasminogen activator (r-tPA) treatment. However, the mismatch criteria suffer from two major issue
Externí odkaz:
https://doaj.org/article/720ab026cdc34323b12a9f3c20d08dd5